bg
A

Acumen Pharmaceuticals (ABOS)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Acumen Pharmaceuticals (ABOS)

Acumen Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a novel disease-modifying approach to target causes of Alzheimer's disease. Acumen Pharmaceuticals serves customers worldwide.

  • USD3.74
  • USD3.77
  • USD3.56
  • USD11.31
  • 5.20%
  • --
  • 79.24k
  • 188.43k
  • 202M
  • 1.81
  • -33.00%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.